Related references
Note: Only part of the references are listed.Emerging Therapeutics, Technologies, and Drug Development Strategies to Address Patient Nonadherence and Improve Tuberculosis Treatment
Maria Garcia-Cremades et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2022)
RCSB Protein Data Bank: improved annotation, search and visualization of membrane protein structures archived in the PDB
Sebastian Bittrich et al.
BIOINFORMATICS (2022)
Re-purposing of hepatitis C virus FDA approved direct acting antivirals as potential SARS-CoV-2 protease inhibitors
Reaz Uddin et al.
JOURNAL OF MOLECULAR STRUCTURE (2022)
In silico study to identify new monoamine oxidase type a (MAO-A) selective inhibitors from natural source by virtual screening and molecular dynamics simulation
Khurshid Jalal et al.
JOURNAL OF MOLECULAR STRUCTURE (2022)
Therapeutic drug monitoring in patients with tuberculosis and concurrent medical problems
Anne-Grete Martson et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2021)
Accelerating AUTODOCK4 with GPUs and Gradient-Based Local Search
Diogo Santos-Martins et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2021)
Development of novel isatin-nicotinohydrazide hybrids with potent activity against susceptible/resistant Mycobacterium tuberculosis and bronchitis causing-bacteria
Zainab M. Elsayed et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)
Comparisons of different force fields in conformational analysis and searching of organic molecules: A review
Toby Lewis-Atwell et al.
TETRAHEDRON (2021)
The interrelationships between antimicrobial resistance, COVID-19, past, and future pandemics
Hyacinth O. Ukuhor
JOURNAL OF INFECTION AND PUBLIC HEALTH (2021)
Pantothenate and CoA biosynthesis in Apicomplexa and their promise as antiparasitic drug targets
Laura E. de Vries et al.
PLOS PATHOGENS (2021)
Improving virtual screening results with MM/GBSA and MM/PBSA rescoring
Harutyun Sahakyan
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2021)
Design of Novel Phosphopantetheine Adenylyltransferase Inhibitors: A Potential New Approach to Tackle Mycobacterium tuberculosis
Marina C. Primi et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2021)
A novel heteromeric pantothenate kinase complex in apicomplexan parasites
Erick T. Tjhin et al.
PLOS PATHOGENS (2021)
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network
Giovanni Battista Migliori et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Inhibitors of pantothenate synthetase ofMycobacterium tuberculosis- a medicinal chemist perspective
Amaroju Suresh et al.
RSC ADVANCES (2020)
Coprevalence of type 2 diabetes mellitus and tuberculosis in low-income and middle-income countries: A systematic review
Hannah Stowe McMurry et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2019)
The Interplay of Human and Mycobacterium Tuberculosis Genomic Variability
Wilian Correa-Macedo et al.
FRONTIERS IN GENETICS (2019)
Coping with healthcare costs for chronic illness in low-income and middle-income countries: a systematic literature review
Adrianna Murphy et al.
BMJ GLOBAL HEALTH (2019)
Inhibition of Pantothenate Synthetase by Analogs of β-Alanine Precursor Ineffective as an Antibacterial Strategy
S. Imindu Liyanage et al.
CHEMOTHERAPY (2019)
Alanine mutation of the catalytic sites of Pantothenate Synthetase causes distinct conformational changes in the ATP binding region
Bharati Pandey et al.
SCIENTIFIC REPORTS (2018)
Expanding the medicinal chemistry synthetic toolbox
Jonas Bostrom et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
OpenMM 7: Rapid development of high performance algorithms for molecular dynamics
Peter Eastman et al.
PLOS COMPUTATIONAL BIOLOGY (2017)
Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors
Ganesh Samala et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Design of Novel Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors: Virtual Screening, Synthesis and In Vitro Biological Activities
Parthiban Brindha Devi et al.
MOLECULAR INFORMATICS (2015)
Structure-Guided Design of Thiazolidine Derivatives as Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors
Parthiban Brindha Devi et al.
CHEMMEDCHEM (2014)
Development of 3-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine derivatives as novel Mycobacterium tuberculosis pantothenate synthetase inhibitors
Ganesh Samala et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Enrichment Factor Analyses on G-Protein Coupled Receptors with Known Crystal Structure
Andrew Anighoro et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)
Recent Advances in the Research of Heterocyclic Compounds as Antitubercular Agents
Mi Yan et al.
CHEMMEDCHEM (2012)
A discovery of novel Mycobacterium tuberculosis pantothenate synthetase inhibitors based on the molecular mechanism of actinomycin D inhibition
Yanhui Yang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
BEAR, a Novel Virtual Screening Methodology for Drug Discovery
Gianluca Degliesposti et al.
JOURNAL OF BIOMOLECULAR SCREENING (2011)
Lead Finder: An Approach To Improve Accuracy of Protein-Ligand Docking, Binding Energy Estimation, and Virtual Screening
Oleg V. Stroganov et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2008)